Evidence map›Paper›PMID 32590145›Full record

ArticleReproductive toxicology (Elmsford, N.Y.)2020

A cross-platform approach to characterize and screen potential neurovascular unit toxicants.

Todd J Zurlinden, Katerine S Saili, Nancy C Baker, Tarja Toimela, Tuula Heinonen, Thomas B Knudsen

Open access · greenAbstract read
In one paragraph

Article in Reproductive toxicology (Elmsford, N.Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 4 countries.

Todd J ZurlindenU.S. Environmental Protection Agency, Office of Research and Development, Center for Computational Toxicology and Exposure, United States.
Katerine S SailiU.S. Environmental Protection Agency, Office of Research and Development, Center for Computational Toxicology and Exposure, United States.
Nancy C BakerLeidos, United States.
Tarja ToimelaFICAM, Faculty of Medicine and Health Technology, Tampere University, Finland.
Tuula HeinonenFICAM, Faculty of Medicine and Health Technology, Tampere University, Finland.
Thomas B KnudsenU.S. Environmental Protection Agency, Office of Research and Development, Center for Computational Toxicology and Exposure, United States. Electronic address: knudsen.thomas@epa.gov.
Environmental Protection Agency · USTampere University · FILeidos (United States) · US

Funding

Intramural EPA EPA999999
6 · The paper itself

Abstract

Development of the neurovascular unit (NVU) is a complex, multistage process that requires orchestrated cell signaling mechanisms across several cell types and ultimately results in formation of the blood-brain barrier. Typical high-throughput screening (HTS) assays investigate single biochemical or single cell responses following chemical insult. As the NVU comprises multiple cell types interacting at various stages of development, a methodology combining high-throughput results across pertinent cell-based assays is needed to investigate potential chemical-induced disruption to the development of this complex cell system. To this end, we implemented a novel method for screening putative NVU disruptors across diverse assay platforms to predict chemical perturbation of the developing NVU. HTS assay results measuring chemical-induced perturbations to cellular key events across angiogenic and neurogenic outcomes in vitro were combined to create a cell-based prioritization of NVU hazard. Chemicals were grouped according to similar modes of action to train a logistic regression literature model on a training set of 38 chemicals. This model utilizes the chemical-specific pairwise mutual information score for PubMed MeSH annotations to represent a quantitative measure of previously published results. Taken together, this study presents a methodology to investigate NVU developmental hazard using cell-based HTS assays and literature evidence to prioritize screening of putative NVU disruptors towards a knowledge-driven characterization of neurovascular developmental toxicity. The results from these screening efforts demonstrate that chemicals representing a range of putative vascular disrupting compound (pVDC) scores can also produce effects on neurogenic outcomes and characterizes possible modes of action for disrupting the developing NVU.

Indexed as

High-Throughput Screening AssaysBiological AssayCells, CulturedEndothelial CellsFibroblastsHazardous SubstancesHumansNeovascularization, PhysiologicNerve NetNeural CrestNeural Stem CellsNeurogenesisHazardous SubstancesAngiogenesisNeurogenesisPredictive toxicologyToxCast

Identifiers

PMID32590145
PMCPMC9773816
OpenAlexW3038117420

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.